Annual Drug Patent Expirations for LIQREV
Liqrev is a drug marketed by Cmp Dev Llc and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
This drug has nine patent family members in nine countries.
The generic ingredient in LIQREV is sildenafil citrate. One supplier is listed for this compound. Additional details are available on the sildenafil citrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
